Nanotechnology|omicsgroup|Journal Of Biotechnology And Biomaterials

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


The application of nanotechnology in the field of drug delivery systems has attracted much attention in the latest decades. Recent breakthroughs have demonstrated that nanoparticle-based drug delivery platforms are an excellent alternative for the efficient delivery of, not only low molecular weight therapeutic agents, but for the release of genes and proteins as well. In the case of intracellular protein delivery, these nanovehicles can accomplish critical functions to achieve the optimal herapeutic effect of protein drugs. For example, one of the roles of nanoparticles is to protect proteins from premature degradation within the biological environment. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021